181 related articles for article (PubMed ID: 10934653)
21. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
[TBL] [Abstract][Full Text] [Related]
23. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
[TBL] [Abstract][Full Text] [Related]
24. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
25. Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells.
Steffen M; Pichlmeier U; Zander A
Bone Marrow Transplant; 1997 Nov; 20(9):715-20. PubMed ID: 9384472
[TBL] [Abstract][Full Text] [Related]
26. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
[TBL] [Abstract][Full Text] [Related]
27. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
[TBL] [Abstract][Full Text] [Related]
28. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
Sadeghi M; Daniel V; Naujokat C; Schmidt J; Mehrabi A; Zeier M; Opelz G
Clin Transplant; 2010; 24(3):415-23. PubMed ID: 19925477
[TBL] [Abstract][Full Text] [Related]
29. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
[TBL] [Abstract][Full Text] [Related]
32. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
33. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
[TBL] [Abstract][Full Text] [Related]
34. Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study.
Tofteng CL; Jensen JE; Abrahamsen B; Odum L; Brot C
J Bone Miner Res; 2002 Aug; 17(8):1535-44. PubMed ID: 12162507
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
36. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
Vestergaard P; Hermann AP; Orskov H; Mosekilde L
J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
[TBL] [Abstract][Full Text] [Related]
37. Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women.
Han KO; Choi JT; Moon IG; Jeong MS; Yim CH; Chung HY; Jang HC; Yoon HK; Han IK
Bone; 2002 Nov; 31(5):612-5. PubMed ID: 12477576
[TBL] [Abstract][Full Text] [Related]
38. Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis.
Benson M; Wennergren G; Fransson M; Cardell LO
Int Arch Allergy Immunol; 2004 Jul; 134(3):227-32. PubMed ID: 15178892
[TBL] [Abstract][Full Text] [Related]
39. Circulating cytokine levels in osteoporotic and normal women.
Khosla S; Peterson JM; Egan K; Jones JD; Riggs BL
J Clin Endocrinol Metab; 1994 Sep; 79(3):707-11. PubMed ID: 8077350
[TBL] [Abstract][Full Text] [Related]
40. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.
Giuliani N; Sansoni P; Girasole G; Vescovini R; Passeri G; Passeri M; Pedrazzoni M
Exp Gerontol; 2001 Mar; 36(3):547-57. PubMed ID: 11250125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
